论文部分内容阅读
美国研究人员在新发表的一篇报告上指出,大麻素受体拮抗类减肥药物可能会危害儿童大脑发育。大麻素受体拮抗剂由于能通过阻断大脑组织中大麻素受体来降低人的食欲,因而被开发成一种新的减肥药物,如法国塞诺菲———安万特制药集团研发的新型减肥药利莫纳班。人们通常说的大麻药
In a newly released report, U.S. researchers pointed out that cannabinoid receptor antagonistic weight-loss drugs may harm the development of children’s brains. Cannabinoid receptor antagonists have been developed as a new drug for weight loss by reducing human appetite by blocking cannabinoid receptors in brain tissue such as the new version developed by the Aventis Pharmaceutical Group Diet pills risimonaban. People usually say cannabis medicine